A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/28 (2006.01)
Patent
CA 2396782
Drugs are formulated as oral dosage forms for controlled release in which the release rate limiting portion is a shell surrounding the drug-containing core. The shell releases drug from the core by permitting diffusion of the drug from the core. The shell also promotes gastric retention of the dosage form by swelling upon imbibition of gastric fluid to a size that is retained in the stomach during the postprandial or fed mode.
Selon l'invention, des médicaments sont préparés en tant que formes posologiques orales destinées à une libération commandée dans laquelle la portion de limitation du taux de libération est une enveloppe placée autour du noyau renfermant les médicaments. L'enveloppe libère le médicament à partir du noyau en permettant sa diffusion à partir du noyau. L'enveloppe favorise également la rétention gastrique de la forme posologique en gonflant lors de l'imbibition de fluide gastrique jusqu'à atteindre une certaine dimension qui est retenue dans l'estomac pendant le mode postprandial ou pendant le repas.
Berner Bret
Gusler Gloria
Louie-Helm Jenny
Shell John N.
Depomed Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Shell-and-core dosage form approaching zero-order drug release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Shell-and-core dosage form approaching zero-order drug release, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Shell-and-core dosage form approaching zero-order drug release will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1502131